Key Points One of the company's revenue generators will likely start feeling a squeeze. Times are not good for pharmacy benefit managers like its Express Scripts. 10 stocks we like better than Cigna Group › Monday wasn't a very good day for health insurers, and if a day's not good for health insurers you can bet Cigna Group(NYSE: CI) stock took it on the chin. The blow came from the highest levels of government, spooking investors and driving down the stock prices of numerous healthcare-institution stocks. Cigna's share price eroded by more than 5%, on a day when the S&P 500 index rose by over 3.2%. A talking-down from Trump Big Healthcare as an industry was hit from two directions on Monday. The first blow came from President Trump, who in signing a new executive order denounced the pharmacy benefit managers (PBMs) that negotiate drug prices for insurers and other healthcare institutions.Image source: Getty Images. "We're going to totally cut out the famous middlemen," Trump said, referring to the PBMs. Prior to that remark, Trump's executive order mandated the pharmaceutical industry to lower its drug prices within 30 days. Additionally, legislation drafted by the House of Representatives contains several measures that could change how the PBMs are compensated. Since both the House and the Senate are controlled by the Republican party, at the moment it seems likely that such a bill has a good chance of being passed into law. Cigna operates one of the most impactful PBMs, Express Scripts. Other healthcare titans with PBMs under their wing also traded down on Monday, particularly CVS Healthcare (CVS Caremark) and UnitedHealth Group (Optum Rx). PBMs on the hot seat Fairly or otherwise, PBMs have been sharply criticized by many healthcare reform advocates for driving up drug prices for Americans. They remain juicy targets for reformers, and it's likely their business will be curtailed one way or another no matter the ultimate fate of that House bill. Still, a company like Cigna is large and sprawling even without its PBM, so I don't see a weakened Express Scripts dragging down its owner all that much. Should you invest $1,000 in Cigna Group right now? Before you buy stock in Cigna Group, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Cigna Group wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider whenNetflixmade this list on December 17, 2004... if you invested $1,000 at the time of our recommendation,you’d have $614,911!* Or when Nvidiamade this list on April 15, 2005... if you invested $1,000 at the time of our recommendation,you’d have $714,958!* Now, it’s worth notingStock Advisor’s total average return is907% — a market-crushing outperformance compared to163%for the S&P 500. Don’t miss out on the latest top 10 list, available when you joinStock Advisor. See the 10 stocks » Story Continues *Stock Advisor returns as of May 12, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool recommends CVS Health and UnitedHealth Group. The Motley Fool has a disclosure policy. Why Cigna Group Stock Dived Today was originally published by The Motley Fool View Comments
Why Cigna Group Stock Dived Today
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...